Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
about
Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotypingNeonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia.How do we treat fetal and neonatal alloimmune thrombocytopenia?Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH.A multicenter validation of recombinant β3 integrin-coupled beads to detect human platelet antigen-1 alloantibodies in 498 cases of fetomaternal alloimmune thrombocytopenia.Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model.External quality assessment in molecular immunohematology: the INSTAND proficiency test program.Assessment of human platelet survival in the NOD/SCID mouse model: technical considerations.
P2860
Q26823205-DA86526F-E214-48EC-9BAC-6D194E616C08Q33405694-50B939AE-D76C-4B2A-8C64-CB888C160F29Q33410953-7455898B-6DB3-45BC-B8F4-7011DAE86FF5Q33414916-009F30E1-5F40-41D1-9113-0A86588E3015Q33420711-39E29897-382F-4666-A7BF-B6AE8B8509C2Q33424394-4C9C2EB3-69A5-434F-908D-A5DBAAAD18F2Q33425658-783BF540-6A5B-4C61-9F68-928139E27363Q33436061-37ED663A-730F-4CA2-96F9-C8CD77C7380AQ33441187-98E9026B-B62B-4094-94F6-C1D9AF6DB727Q37315703-BD986AF8-039C-477C-9242-BCC57A0B91ECQ53120483-26B1CE64-E16F-4933-AA3F-F4A1B6CA71B8
P2860
Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prevalence and clinical signif ...... ed to HPA-1a during pregnancy.
@ast
Prevalence and clinical signif ...... ed to HPA-1a during pregnancy.
@en
type
label
Prevalence and clinical signif ...... ed to HPA-1a during pregnancy.
@ast
Prevalence and clinical signif ...... ed to HPA-1a during pregnancy.
@en
prefLabel
Prevalence and clinical signif ...... ed to HPA-1a during pregnancy.
@ast
Prevalence and clinical signif ...... ed to HPA-1a during pregnancy.
@en
P2093
P2860
P1433
P1476
Prevalence and clinical signif ...... sed to HPA-1a during pregnancy
@en
P2093
Adam Kanack
Daniel W Bougie
Dhirendra Nayak
Janice G McFarland
Julie A Peterson
Richard H Aster
P2860
P304
P356
10.1111/J.1537-2995.2012.03903.X
P50
P577
2012-09-25T00:00:00Z